CoChat

Amyloid‐β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease

Open access
Lublin, Alex L., Gandy, Sam · 2010 · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
Cited by 120

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease is the most common form of senile dementia. Although the amyloid‐β peptide was identified in 1984 as the major constituent of the senile plaques that characterize the disease, accumulating evidence indicates that the plaque density does not correspond well to the concurrent disease state. In order to resolve this disconnect, a number of recent studies have shifted away from the senile plaque and classical fibrillar forms of amyloid toward a less well structured species as the proximate neurotoxic factor underlying cognitive failure in Alzheimer's disease: soluble amyloid‐β peptide oligomer (also known as the amyloid‐β peptide–derived diffusible ligand). Paradoxically, several studies in the last 2 years have shown that picomolar levels of amyloid‐β peptide have neutral activity or perhaps even an essential role in learning and memory. Here we highlight some of the key observations underlying the growing focus on the amyloid‐β peptide oligomer. Mt Sinai J Med 77:43&–49, 2010. © 2010 Mount Sinai School of Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/msj.20160

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 120

Metadata

Authors
Lublin, A. L., & Gandy, S.
Venue
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
Publisher
Wiley
Published
2010-01
Volume
77
Issue
1
Pages
43-49
ISSN
  • 0027-2507 (ISSN-L)
  • 1931-7581
OpenAlex
W2131449630
Cited by
120
References
10
FWCI
7.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.